Unichem Laboratories informs about press release

16 Mar 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it enclosed a press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem’s Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg.

The above information is a part of company’s filings submitted to BSE.

Unichem Lab Share Price

324.05 0.60 (0.19%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×